Itacitinib and Alemtuzumab in Treating Patients With T-Cell Prolymphocytic Leukemia
Clinical trial NCT03989466 · COMPLETED
Trial details
- NCT number
- NCT03989466
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-15
- Primary completion
- 2024-09-24
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.